Acute hyperglycemia may contribute to the progression of atherosclerosis by regulating protein kinase C (PKC) isozymes and by accelerating vascular smooth muscle cell (VSMC) proliferation. We investigated acute glucose regulation of PKCb gene expression in A10 cells, a rat aortic smooth muscle cell line. Western blot analysis showed that PKCbII protein levels decreased with high glucose (25 mM) compared to normal glucose (5.5 mM), whereas PKCbI levels were unaltered. PKCb mRNA levels were depleted by 60-75% in hyperglycemic conditions. To elucidate whether high glucose regulated PKCb expression via the common promoter for PKCbI and PKCbII, deletion constructs 
. PKC, a serine/threonine kinase, is the cellular receptor for diacylglycerol and tumor-promoting phorbol esters. PKC is involved in signal transduction, tumor promotion, gene expression, and cell proliferation and differentiation (7, 8) . PKC consists of a family of 11 closely related isozymes that are activated by various combinations of Ca 2/ , phospholipid, and diacylglycerol. Conventional protein kinase C (Ca 2/ dependent) includes PKCs a, bI, bII, and g. Novel protein kinase C (Ca 2/ independent) and atypical protein kinase C include PKCs d, e, h, u, l/i, z, and m (2, 9, 10). PKC isozymes show distinct tissue, cellular, and subcellular distribution although the same cell type may express more than one isozyme (8, 11, 12) . PKCbI and PKCbII are derived from the alternative splicing of the 3 exon of a single PKCb gene (13) . Both PKCbI and PKCbII are present in VSMC. In quiescent cells, PKCbII is the predominant isoform detected on Western blots. Smooth muscle cells in the arterial wall normally exist in a quiescent state until recruited to proliferate.
Complications involved in cardiovascular tissue injury recovery are aggravated by episodes of acute hyperglycemia. The response to injury theory proposed by Ross (14) suggests that injury to the epithelium leads to the production of growth factors and cytokines, which stimulate smooth muscle cell movement into and proliferation within the arterial intima. Diabetic conditions, especially acute hyperglycemia, may provoke the excessive formation of atherosclerotic lesions, which may ultimately lead to the formation of the fibrous plaques (1) . This study eluci-dates molecular events occurring after initiation of the cell cycle in quiescent vascular smooth muscle cells after exposure to acute hyperglycemic conditions. In previous studies, only PKC activity and protein levels were examined after chronic glucose exposure; no experiments were performed to determine the effects of acute exposure to high glucose on PKCb gene processing in proliferating cells from the macrovasculature. Prolonged exposure to high glucose leads to glucose-induced PKC activation in rat nerves, adipocytes, and soleus muscles, followed by the down-regulation of PKC activity (15) (16) (17) . PKCb2 levels were elevated in vascular aortic cells from diabetic rats exposed to high glucose levels for 2 to 4 months and in VSMC cultured under chronic high glucose conditions for 5 to 10 days (5, 18, 19) . These studies demonstrated an increase in membrane PKCbII activity as a result of increased translocation from the cytosol in cells from vascular tissue. However, the conditions of acute hyperglycemia used here to study PKCb gene expression in vascular smooth muscle cells more closely mimicked the 'response to injury model' proposed by Ross (14) .
Our previous studies indicated that PKCbI and PKCbII regulate the vascular smooth muscle cell cycle. In A10 cells (a clonal cell line of VSMC) overexpressing PKCbII, DNA synthesis was attenuated (20) . This suggested that PKCbII may function as a cell cycle mediator during G1/S phase transition in VSMC. We found that PKCbII protein expression was decreased and the percentage of A10 cells entering the S phase was increased in VSMC in the presence of acute high extracellular glucose concentrations (32) . On the basis of these findings, we hypothesized that the hyperglycemia-induced proliferation of VSMC may be related to glucose regulation of PKCb gene expression. In this study, we investigated molecular mechanisms through which high glucose could regulate PKCb gene expression in proliferating VSMC. Hyperglycemic conditions down-regulated PKCbII gene expression as reflected by protein and mRNA levels, whereas PKCbI levels remained unchanged between high and normal glucose conditions. Glucose induced posttranscriptional destabilization of PKCbII messenger RNA through cytosolic nuclease activity. The specificity of glucose-induced destabilization was confirmed via reverse transcriptase-polymerase chain reaction (RT-PCR), for PKCbII mRNA while not significantly altering PKCbI mRNA. Primary cultures from human aortic muscle cells demonstrated the same phenomenon.
MATERIALS AND METHODS

A10 cells
The vascular smooth muscle cell line (A10, ATCC CRL 1476), derived from rat aorta, was grown in Dulbecco's modified Eagle's medium (DMEM with 5.5 mM glucose) containing 10% fetal bovine serum (FBS), and 100 units penicillin G, and 100 mg streptomycin sulfate/ml at 37ЊC in a humidified 5% CO 2 , 95% air atmosphere in either 6-well plates (for promoter studies, Western blot analysis, [ 3 H]thymidine uptake assay) or 100 mm plates (for Northern blot analysis, RNA stability assay). Cells were grown to 80% confluency and medium was changed every 4 days. G 0 /early G 1 phase synchronization was achieved by serum deprivation, that is, by culturing the A10 cells in DMEM with 5.5 mM glucose containing 0.5% FBS for 48 h (22) . Cells were reinitiated to proliferate by changing the medium to DMEM with 5.5 mM glucose containing 10% FBS.
Primary cultured human aortic smooth muscle cells (AoSMC) (Clonetics, San Diego, Calif.) were grown in SmGM (Clonetics) medium containing 5.5 mM glucose, 5% FBS, 10 ng/ml human recombinant epidermal growth factor, 390 ng/ ml dexamethasone, 50 mg/ml gentamicin, and 50 ng/ml amphotericin-B (according to recommendation by Clonetics) at 37ЊC in a humidified 5% CO 2 , 95% air atmosphere. Cells were grown to 80% confluency and medium was changed every 5 days. Cell synchronization was achieved by serum deprivation, culturing the aortic smooth muscle cells in SmGM with 5.5 mM glucose (basal medium) containing 0.5% FBS for 72 h (22) . Cells were reinitiated to proliferate by changing the medium to SmGM with 5.5 mM glucose containing 5% FBS.
Isolation of RNA and Northern blot analysis
Total cellular RNA was isolated from 100 mm plates using RNAzol B (Tel-Test, Inc., Tex.). RNA samples (10 mg) were prepared in formamide, formaldehyde, and 11 MOPS, and fractionated on 1.2% agarose-formaldehyde gels. Ethidium bromide (0.5 mg/ml) was added to the loading buffer. After fractionation, the integrity and loading of 18S and 28S RNA were assessed under UV light as described (17, 23, 24) . The size-fractionated RNA was then capillary transferred to Hybond membranes (Amersham, Arlington Heights, Ill.), and the uniform transfer of RNA was assessed by visualizing 18S and 28S RNA on the membrane. RNA was then cross-linked to membranes by baking at 80ЊC in a vacuum oven for 2 h. Membranes were hybridized overnight at 42ЊC with 2 1 10 7 cpm of the full-length PKCb cDNA probe (labeled with [ 32 P] dCTP by nick translation, as described) (25) per ml of hybridization buffer. Membranes were washed with high stringency conditions, and quantitated using the Molecular Dynamics Phosphoimaging System. Where mentioned, membranes were exposed to X-ray film and the autoradiograms were quantitated densitometrically. For RNA stability assessment, A10 cells were pretreated with 5 mg/ml actinomycin D (Sigma) for 30 min, then incubated with medium containing 5.5 mM or 25 mM glucose. Each Northern blot analysis was repeated at least three times to confirm reproducibility.
Western blot analysis
Synchronized A10 cells were incubated with 5.5 mM (normal or low) or 25 mM (high) glucose for 6, 10, 14, or 18 h. Cell lysates were analyzed as described previously (25) . PKCbI and PKCbII antibodies were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, Calif.). After incubation with primary antibody, blots were developed with the enhanced chemiluminescence (ECL) kit (Amersham Corp.).
Calcium phosphate transfections
For promoter studies, A10 cells were cultured in 6-well plates and synchronized in DMEM with 5.5 mM glucose containing 0.5% FBS for 48 h. To reinitiate cell proliferation, fresh me-/ 383e ja18 Mp 105 Wednesday Dec 09 11:26 AM LP-FASEB ja18 dium (DMEM with 5.5 mM glucose containing 10% fetal bovine serum) was substituted on A10 cells. PKCb-chloramphenicol acetyltransferase (CAT) expression plasmids containing varying 5 upstream sequences of PKCb with a constant 3 end at position /179 base pairs (bp) inserted upstream of CAT (chloramphenicol acetyltransferase) structural gene in the promoterless CAT plasmid were obtained from S. Ohno (26) . Each construct (3.5 mg) ligated to CAT as reporter gene (27) was transfected into A10 cells using calcium phosphate-DNA precipitates (28) . The pSV-b-galactosidase vector (2 mg) was cotransfected for normalization of transfection efficiency (29) . The pSVACAT plasmid containing neither promoter nor enhancer activity was used as negative control. pCAT plasmid containing the SV40 promoter and enhancer sequences was used as the positive control. Twenty-four hours later, calcium phosphate-DNA precipitate was washed off with 11 Dulbecco's phosphate-buffered saline (DPBS) and replaced with fresh medium containing either 5.5 or 25 mM glucose, or 5.5 mM glucose / 100 nM 12-O-tetradecanoylphorbol-13-acetate (TPA). Cells were extracted after 6 h or periodically over 24 h (for simultaneous cell cycle studies), using reporter lysis buffer (Promega cat # E1000), and assayed for CAT activity and b-galactosidase activity (30) . A negative control extract, prepared from mock transfected A10 cells, was assayed for the presence of endogenous b-galactosidase activity. CAT activity was normalized to b-galactosidase activity.
RNA stability assay
To prepare postnuclear extracts (31) , synchronized A10 cells reinitiated to proliferate with DMEM / 10% FBS were treated with either 5.5 or 25 mM glucose for 2 h to 24 h, then washed and collected in ice-cold 11 DPBS. The cellular pellet was resuspended in extract buffer containing 0.01 M Tris-HCl, 0.15 M NaCl, 0.5% Nonidet P-40, leupeptin (10 mg/ml), and aprotinin (10 mg/ml), incubated on ice for 10 min and carefully layered over extract buffer containing 24% sucrose. Samples were centrifuged over a sucrose gradient at 10,000 1 g for 20 min at 4ЊC. Postnuclear extract was separated, stored on ice, and aliquots taken for protein concentration using BioRad protein assay. Total RNA (10 mg) from A10 cells was incubated with 2.7% (vol/vol) of the postnuclear extracts for 30 min at 4ЊC in 50 ml (final volume) of extract buffer. When specifically noted, 50 mM EDTA was added to the reactions as a control to inhibit nuclease activity. The reactions were terminated by phenol-chloroform extraction, supplemented with 10 mg yeast tRNA as carrier, and precipitated with ethanol. RNA was fractionated on 1.2% formaldehyde-agarose gels and Northern blot analysis was carried out with full-length PKCb cDNA probe. The assay and analyses was repeated at least three times with separate postnuclear extracts to assess and confirm reproducibility.
Reverse transcriptase-polymerase chain reaction
Total RNA was isolated from control (5.5 mM glucose) or glucose-treated (25 mM glucose) A10 cells and 2 mg was used to synthesize first strand cDNA using an Oligo(dT) primer and Superscript II reverse transcriptase (Life Technologies preamplification kit). The upstream sense primer corresponded to the C4 kinase domain common to both PKCbI and PKCbII (5 CGTATATGCGGCCGCGTTGTGGGCCTGAAGGGG 3), and the downstream antisense primer was specific for PKCbI (5 GCATTCTAGTCGACAAGAGTTTGTCAGTGGGAG 3) (25) . These primers detect inclusion of the PKCbII exon in the mature mRNA as well as PKCbI mRNA. Sense and antisense primers for b-actin (#5402-3) were obtained from Clontech (Palo Alto, Calif.). PCR was performed using ampliTaq Gold DNA polymerase from Perkin-Elmer (#N808-0240) on 10% of the reverse transcriptase reaction product. After 35 cycles of amplification in a Biometra Trioblock thermocycler (PKCbI and bII: 95ЊC, 30 s; 64ЊC, 2 min for 35 cycles; and for b-actin: 94ЊC, 1 min; 58ЊC, 1 min; and 72ЊC, 3 min for 35 cycles), 25% of the PCR reaction was resolved on a 1.2% agarose gel. Bands were observed under UV light and photographed.
RESULTS
PKCbII protein levels decreased when A10 cells were exposed to 25 mM glucose
To better understand the biochemical mechanism underlying the acute effects of high glucose exposure on PKCb expression in aortic vascular smooth muscle cells, protein levels of PKCbI and bII were determined in synchronized A10 cells. Cell growth synchronization was achieved by serum deprivation for 48 h, as described in Materials and Methods; after synchronization, medium on A10 cells was replaced with DMEM containing 10% FBS to reinitiate cell proliferation and incubated with high (25 mM) or normal (5.5 mM) glucose. Over a 24 h period, protein was extracted at various times from cells reinitiated by addition of serum to proliferate. As cells progressed through the cell cycle, the expression of PKCbII appeared to be cell cycle associated, with highest levels of protein expression observed at 6 and 18 h and lowest levels occurring at 14 h. PKCbII protein levels in cells treated with high glucose dramatically decreased (by 55%) within the first 6 h and remained low after 14 h of continuous high glucose treatment, beginning to return at 18 h (Fig. 1b) . No significant changes in PKCbI protein levels were detected between high and normal glucose treatments (Fig. 1a) . To check the specificity of high glucose to down-regulate PKCbII, Western blot analysis was repeated using primary antibodies to PKCa and PKCe. Again, no significant changes in PKCa or e protein levels were detected between high and normal glucose treatments (data not shown). Thus, the downregulation by acute glucose appeared specific for the PKCbII isoform.
Hyperglycemic conditions markedly reduce PKCb(I/II) mRNA in A10 cells
To determine the acute effects of hyperglycemia on PKCb gene expression, steady-state levels of PKCb mRNA were examined in synchronized A10 cells (by serum deprivation for 48 h as described in Materials and Methods) that were reinitiated by changing the medium to DMEM containing 10% FBS and incubated overnight with either high (25 mM) or normal (5.5 mM) glucose. Cells incubated with 25 mM man-/ 383e ja18 Mp 106 Wednesday Dec 09 11:26 AM LP-FASEB ja18 Figure 1 . PKCbII protein levels decreased by 55% in the presence of high glucose. A10 cells were synchronized by culturing the cells in DMEM containing 0.5% FBS for 48 h. To reinitiate the cell cycle, A10 cells were incubated in DMEM with 10% FBS containing 5.5 mM glucose (control cells) or 25 mM glucose (hyperglycemic condition) for indicated periods up to 18 h. Western blot analysis was carried out on cell lysates using anti-PKCbI (a) and anti-PKCbII (b) as primary antibodies. Proteins were detected using enhanced chemiluminescence (ECL; Amersham) as described in Materials and Methods. Densitometric scanning was used to quantify PKCbI and PKCbII bands from the blots. The graphs depict PKCbI and PKCbII protein levels in the presence of 25 mM glucose plotted as the percent of the total PKCbI and PKCbII levels present in the respective control (5.5 mM glucose) cells. Data are representative of at least five separate experiments.
nitol were used as osmotic controls. Total RNA was extracted and the mRNA transcript levels were detected using a full-length PKCb cDNA probe that would cross-hybridize with both PKCbI and PKCbII mRNAs. As shown in Fig. 2 , a 60-75% decrease in PKCb(I/II) mRNA levels was observed in cells treated overnight with high glucose (25 mM). The mRNA levels in the control cells (5.5 mM glucose) and osmotic control cells (mannitol-treated) remained unchanged. This suggested that high glucose down-regulated PKCb(I/II) gene expression. Since protein analysis after high glucose exposure indicated a decrease only in PKCbII levels, it was assumed that the Northern blot analysis reflected a down-regulation of PKCbII mRNA whereas PKCbI mRNA remained constant. Since PKCbII is the product of PKCb mRNA alternatively splicing, the possibility existed that transcriptional and posttranscriptional controls were altered by high glucose.
Glucose quenches PKCb promoter activity
Our studies indicated that PKCbII levels 'cycled' with synchronized A10 cells during a 24 h period (32) . We chose to systematically study the effect of high glucose on PKCb promoter activity in synchronized A10 cells. Glucose may be exerting its effect on PKCb gene expression through a response element located in the common promoter upstream of the transcription start site, as reported with L-PK and S14 gene expression in hepatocytes (20, (33) (34) (35) (36) . Since PKCb is a low copy gene, nuclear run-on assays were not a practical approach to examine transcriptional regulation. Hence, the PKCb-CAT expression plasmids cloned by S. Ohno (Yokohama College of Medicine) (26) were used to study transcriptional regulation of PKCb gene expression by glucose. PKCb promoter constructs with successive deletions of the 5 region cloned in front of a promoterless CAT as the reporter gene were transiently transfected into A10 cells (Fig.  3a) . pSV-b-Galactosidase was cotransfected with the CAT constructs to normalize the efficiency of transfection. Simultaneous positive and negative controls were performed as described in Materials and Methods. Transcriptional repression of PKCb promoter by transcription factors in response to high glucose was anticipated. However, in A10 cells incubated with high glucose (25 mM) for 6 h, a moderate decrease or quenching in the PKCb promoter activity of constructs A (04.1 kb to /179CAT), C (0674 to /179CAT), and D (0411 to /179CAT) was observed (Fig. 3b) . Construct E (0234 to /179CAT) showed no quenching with glucose indicating that a putative carbohydrate response element had been deleted. Construct E contains the basal response elements required for promoter activity and was not affected by glucose concentrations. Thus, construct D contained the elements involved in maximum quenching of promoter activity, presumably within a 177 bp region which was deleted in construct E. In parallel experiments, a control with 100 nM TPA increased the promoter activity by 10-fold in all constructs. This confirmed the response of PKCb basal promoter element with phorbol esters (37) .
In the case of transcriptional repression, DNA binding is inhibited by repressors blocking the binding site for a factor or forming a non-DNA binding protein-protein complex resulting in inhibition of transcription. The reduction in promoter activity observed here did not account for the dramatic downregulating effect of glucose on total PKCb mRNA. If glucose effects were mediated exclusively at the tran- scriptional level, total repression would have occurred. The reduction in promoter activity observed here is most likely explained as a quenching effect that involves interfering with transcriptional activation by a DNA-bound factor (38) . An example of transcriptional quenching is illustrated by the yeast factor GAL80, which inhibits gene activation by the positively acting GAL4 protein in the regulation of galactose in yeast (44) . Since the extent of quenching of the PKCb promoter by glucose varied depending on the time points examined, the results suggested that as cells progress through the cell cycle, high glucose regulation of PKCb gene expression may be cell cycle mediated. Simultaneous cell cycle studies indicated an increase in the percentage of cells going into S phase in high glucose, implying that quenching of PKCb transcription may be related to cell cycle progression (N. A. Patel, M. Yamamoto, and D. R. Cooper, unpublished observations).
PKCb message is destabilized by glucose
Since the quenching of PKCb promoter activity by acute high glucose did not account for the 60-75% reduction in PKCb mRNA levels as observed by Northern blot analysis (Fig. 2) , the major effect of glucose may be exerted posttranscriptionally. However, high glucose also diminished PKCbII protein levels, suggesting that high glucose could affect the stability of the PKCbII transcript at the posttranscriptional level. Northern blot analysis of PKCb(I/II) mRNA level (see Materials and Methods) was performed on total RNA from synchronized A10 cells. Upon reinitiation of proliferation by DMEM / 10% FBS, A10 cells were pretreated with actinomycin D for 30 min, followed by incubation with normal or high glucose. The mRNA levels were detected using the full-length PKCbII cDNA probe, which recognizes both PKCbI and PKCbII mRNA. A10 cells exposed to high glucose showed a decrease in PKCb(I/II) mRNA levels within 2 h of treatment (Fig. 4) ; levels decreased further to 60% of control by 6 h. Thus, the results suggested that posttranscriptional destabilization of PKCbII mRNA by glucose was also occurring.
In vitro assay for RNA destabilization
To assess the involvement of a nuclease activity in the destabilization of PKCb mRNA by glucose, an in vitro RNA stability assay was performed (31) . A10 cells incubated with 5.5 or 25 mM glucose for 2, 6, 18, and 24 h were used to prepare control postnuclear extracts (control PNE) or glucose-treated postnuclear extracts (glucose PNE). Total RNA isolated from untreated A10 cells was incubated with 2.7% (vol/vol) postnuclear extracts or glucose-treated postnuclear extracts from A10 cells in 50 ml total volume of extract buffer. RNA incubated without postnuclear extracts was used as a positive control. A reaction with no RNA served as the negative control. Since involvement of divalent cations is a feature of some ribonucleases that regulate mammalian RNA turnover, EDTA was added to postnuclear extracts to distinguish nuclease activity from cyclizing RNases and acid lysosomal RNase. Northern blot analysis was then performed to detect nondegraded PKCb(I/II) mRNA. Incubation of RNA with postnuclear extracts from synchronized A10 cells treated with 25 mM glucose for 2 and 6 h showed 45% and 65% decreases, respectively, in PKCb(I/II) RNA levels whereas incubation for 18 and 24 h showed 8% and 12% decreases, respectively, in PKCb(I/II) RNA levels (Fig. 5a) . No degradation of RNA was observed in the presence of EDTA either in the control or high glucose-treated postnuclear extracts (Fig. 5b) . These results indicate the activation of a divalent cation-dependent (31, 39) nuclease activity by high glucose. The destabilization of PKCb(I/II) mRNA by glucose accounted for a significant down-regulation of PKCbII expression, although these observations suggested that destabilization of PKCbII mRNA occurred as an early event in the regulation of mRNA processing by high glucose.
Specificity of mRNA destabilization by glucose
Since a full-length PKCb cDNA probe was used for analysis of PKCb(I/II) RNA levels by the Northern blot analysis, RT-PCR was performed on total RNA from A10 cells to determine the specificity of high glucose to down-regulate PKCbII mRNA rather than PKCbI mRNA. It had been demonstrated earlier that mature PKCbII mRNA results from differential processing leading to in PKCbII exon inclusion into PKCbI mRNA transcript (25, 40) . Thus, the PKCbII transcript contains the PKCbI exon with the poly A tail and a common 3 untranslated region (UTR) (Fig. 6a) . Inclusion of the alternatively spliced exon encodes a stop codon such that the PKCbI exon facilitates poly-adenylation but the exon is not translated, thereby generating PKCbII protein. Primers were designed for the upstream common kinase region (C4) (-sense primer) and the PKCbI exon (-antisense primer) for simultaneous amplification of both PKCbI and -bII messages by RT-PCR. In control A10 cells (5.5 mM glucose), both PKCbI and PKCbII PCR products were detected. Although this assay is semiquantitative, the ratio of PKCbII to PKCbI mRNA was about 2 to 1. In glucose-treated (25 mM) A10 cells, PKCbII PCR product decreased ú90%, whereas PKCbI mRNA level did not show any signif- At time zero, glucose was added such that the medium contained 5.5 mM (Con) or 25 mM glucose (Glc). Total RNA was extracted from 0 to 6 h and 10 mg of RNA was fractionated on 1.2% agarose-formaldehyde gels; 28S and 18S rRNA were visualized to ensure equal loads of RNA (lower panel), capillary transferred to Hybond membrane (Amersham), and probed with a 32 P-labeled PKCb cDNA probe that detects PKCb(I/II) mRNA, as described in Materials and Methods. Images of the 3.5 kb transcript were quantitated using Molecular Dynamics Phosphoimaging system and are representative of three individual experiments. The graph depicts PKCb(I/II) mRNA levels in the presence of 25 mM glucose plotted as the percent of the total PKCb(I/II) mRNA levels present in the control (5.5 mM glucose) cells. A 60% decrease (*significance at Põ0.05) in PKCb(I/II) mRNA is seen at 6 h with glucose-treated cells. Figure 5 . in vitro assay for RNA stability. a) Postnuclear extracts were prepared from A10 cells treated with either 5.5 mM glucose (control cells) or 25 mM glucose (glucose-treated cells) for 2, 6, 18, or 24 h . Total RNA (previously extracted from synchronized A10 cells) was incubated for 30 min at 4ЊC with 2.7% (vol/vol) postnuclear extracts from control (5.5 mM glucose) or 25 mM glucose-treated A10 cells in a 50 ml total reaction volume. Northern blot analysis for PKCb(I/II) mRNA was then performed on the RNA as described in Materials and Methods. Images of the 3.5 kb bands were quantitated by phosphoimaging and are representative of four individual experiments with similar results. The graph shows the total PKCb(I/II) mRNA levels remaining after incubation with postnuclear extracts from glucose-treated cells plotted as a percent of the total PKCb(I/II) mRNA in the respective control incubations with postnuclear extracts from cells treated with 5.5 mM glucose. Protein concentrations of control (5.5 mM glucose) postnuclear extracts (control PNE) and 25 mM glucose-treated postnuclear extracts (glucose PNE) at 2 h were 2.5 and 2.23 mg/ml, respectively; at 6 h, protein levels were 1.34 mg/ml and 1.34 mg/ml, respectively; at 18 h, levels were 1.3 and 1.25 mg/ml, respectively; and at 24 h, levels were 1.22 and 1.27 mg/ml, respectively. b) No degradation of total RNA by glucose-treated postnuclear extract was observed when 50 mM EDTA was added to the reaction mix as described above. Similar results were obtained in three separate experiments. icant change. b-Actin levels remained constant in both control and glucose-treated A10 cells (Fig. 6b) . Thus, PKCbII mRNA was specifically destabilized in response to 25 mM glucose.
To extend the physiological significance of the down-regulation of PKCbII by high glucose, we repeated the RT-PCR described above using primary cultured aortic smooth muscle cells from humans (AoSMC CC2571, Clonetics Normal Human Cell System). In high glucose medium (25 mM glucose), (Fig. 6c) . Since cells from human primary culture responded in the same manner, the / 383e ja18 Mp 110 Wednesday Dec 09 11:26 AM LP-FASEB ja18 Figure 6 . High glucose destabilizes PKCbII mRNA. a) A schematic representation of the PKCb as deduced from cDNA sequence analysis. The shaded blocks C1-C4 represent the conserved regions whereas V1-V5 blocks represent variable regions. The regulatory and the catalytic domains are separated by V3, which serves as a hinge region. PKCbI and -bII, the alternatively spliced products of PKCb pre-mRNA, diverge in their carboxyl-terminal sequence by 50 or 52 amino acids, respectively. The enlarged area represents the genomic structure of the alternatively spliced V5 region. Lines represent introns and blocks represent exons. The arrows indicate the regions that correspond to the sense primer (the last common region (C4) for PKCbI and -bII) and antisense primer (to the bIV5 region) used for amplification of both PKCbI and -bII cDNAs simultaneously. b) RT-PCR was performed on total RNA isolated from A10 cells synchronized by serum starvation for 48 h or c) from primary cultures of AoSMC from humans synchronized by serum starvation for 72 h. Cells were reinitiated to proliferate by serum introduction to the basal medium and incubated with 5.5 mM glucose (control) or 25 mM glucose (glucose-treated) for 4 h. The first strand cDNA synthesized was amplified using a sense primer to the common C4 domain and antisense primer to the PKCbI exon. The PCR product size was 187 bp for PKCbI; 404 bp for PKCbII, and 550 bp for b-actin. PKCbII mRNA was decreased ú95% by 25 mM glucose treatment whereas PKCbI mRNA remained unchanged. No change was observed in the b-actin PCR products in 5. A10 cells proved to be a reliable model for studying the effects of high glucose on PKCb gene expression in vascular smooth muscle cells.
DISCUSSION
Injury to the endothelium and arterial smooth muscle cells triggers the formation of fibrous lesions. Incidences of acute high glucose exposure can further aggravate the formation of these occlusive lesions (1). Our prior studies indicated that the expression and functions of PKCbI and PKCbII were cell cycle associated (32) . In A10 cells overexpressing PKCbII, cellular DNA synthesis was attenuated whereas in cells overexpressing PKCbI, proliferation was sustained (32) . In AoSMC and A10 cells, PKCbI and -bII stimulated and inhibited the G1/S phase transition, / 383e ja18 Mp 111 Wednesday Dec 09 11:26 AM LP-FASEB ja18 respectively (32). We investigated several molecular mechanisms by which glucose may regulate PKCbII gene expression in VSMC. The elucidation of these regulatory phenomena is essential since the depletion of PKCbII levels in response to acute hyperglycemia can accelerate cellular proliferation that may be directly involved in the development of occlusive atherosclerotic lesions.
Glucose regulation of PKCb gene expression in VSMC may occur at transcriptional, posttranscriptional, translational, or posttranslational levels. The potential sites of regulation included repression of transcription, improper nuclear export of PKCbII mRNA, posttranscriptional destabilization, decreased translation, or multiple effects culminating in decreased PKCbII protein levels. PKCbII protein levels declined sharply after high glucose exposure whereas PKCbI protein levels did not change significantly between high and normal glucose conditions. Since protein levels often reflect the amount of mRNA transcribed, steady-state levels of PKCb mRNA were determined. It followed that the decrease in PKCb(I/II) mRNA levels observed in A10 cells exposed to high glucose was likely due to down-regulation of PKCb gene expression.
Since PKCbI and PKCbII share a common DNA promoter, transcriptional processing of PKCb in VSMC was examined to determine whether high glucose down-regulated PKCb gene expression by repressing promoter activity. Hyperglycemic conditions, however, only quenched activities of PKCb promoter constructs rather than repress promoter activity, and accounted for only a fraction of the effect of high glucose on PKCbII protein levels.
It is possible that glucose may be exerting its quenching effect through a response element located upstream of the transcription start site. A carbohydrate response element (ChoRE) that mediates its action via glucose had been reported (35, 41) . The consensus sequence, 5 CACGTG 3, was described in the promoter region of a number of glucose responsive genes including L-PK (34) and S-14 in hepatocytes (20, 33, 36) . Multiple copies of CACGTG motif are found in the region upstream of the transcription initiation site of the PKCb promoter region. It was likely that glucose may play a role as a quencher of positively acting regulatory factors by binding to or otherwise activating a ChoRE. Construct D (0411 to /179CAT) contains a ChoRE motif in proximity to the CAAT box and AP 2 binding site (TATA box and AP 1 binding site have been deleted). The ability of a bound trans-acting factor to stimulate transcription via its activation domain may be inhibited by quenching of the activation domain by glucose, which could either bind to the trans-acting factor without directly binding to DNA or bind to a site adjacent to the transacting factor (38) .
We further investigated whether high glucose affected the posttranscriptional processing of PKCb transcripts since quenching of PKCb promoter activity did not fully explain the reduction in PKCb mRNA levels. A10 cells exposed to high glucose showed a decrease in PKCb(I/II) mRNA stability within 2 h in the presence of actinomycin D, indicating an increase in message degradation was occurring. The induction or activation by glucose of a nuclease activity involved in the destabilization of PKCbII mRNA was demonstrated by an RNA stability assay. This divalent cation-dependent nuclease activity was distinct from cyclizing RNases and acid lysosomal Rnase, since its activity was inhibited by EDTA.
To confirm that glucose specifically destabilized the PKCbII mRNA isoform, RT-PCR was performed using primers that amplified PKCbI and PKCbII mRNA simultaneously. High glucose destabilized PKCbII mRNA whereas PKCbI mRNA was not affected. Since the mature PKCbII mRNA is generated by exon inclusion (25, 40) and both PKCbI and PKCbII transcripts contain the PKCbI exon and share a common 3 UTR (Fig. 6a) , the destabilizing elements appear to be present within the PKCbII exon or are introduced around the splice sites between the exons. This is a novel observation since the destabilization elements regulated by glucose occur within the coding area of PKCbII exon rather than in the 3 UTR.
Our studies were extended to primary human AoSMC cultures where we demonstrated that glucose also induced PKCbII destabilization. The combined effects of high glucose on transcriptional quenching of the PKCb promoter and specific destabilization of the PKCbII transcript account for the reduction of PKCb mRNA levels observed under steady-state conditions in rat and human proliferating aortic smooth muscle cells. The human primary cultures further underscore the physiological relevance of acute high glucose effects on vascular smooth muscle cell proliferation. In other studies, we used CGP53353 a PKCbII-specific inhibitor to demonstrate that CGP53353 inhibits glucose-stimulated rat VSMC proliferation (M. P. Yamamoto, N. A. Patel, and D. R.
Cooper, unpublished observations).
Earlier studies showed that prolonged exposure to high glucose for 2-4 months might lead to an elevation of PKCb levels in vascular tissues (4, 5, 18, 19, 42) . Using an inhibitor for PKCb on diabetic rats, Inoguchi et al. (19) suggested that the activation of PKCbII might be a key step through which glucose triggers diabetic complications in microvascular cells. It might seem that certain discrepancies exist between these observations and our present experiments. However, these investigators carried out their experiments using in vivo diabetic rat models subjected to chronic glucose exposure for 2 to 4 months (5, 19) . PKC activity was examined in nonsynchro-nized VSMC cultured under chronic high glucose conditions for 5 to 10 days (5, 18, 19, 42) . Here, we studied the effects of high glucose on PKCbI and PKCbII mRNA on synchronized VSMC during the first cell cycle postsynchronization and demonstrated that glucose-induced destabilization of PKCbII mRNA occurs during the course of the cell cycle. Also, instead of PKCbII, the PKCb2 nomenclature has been used on occasions that would imply that PKCbI was the isoform increased by hyperglycemia (40, 43) . Moreover, King and co-workers (5, 18, 19) reported an increase in the PKC activity as reflected by increases in the membrane PKC fraction under chronic glucose conditions. In none of these studies were PKCb mRNA levels examined with acute glucose exposure. Our present studies examined the regulation exerted by acute glucose exposure on the PKCb gene and have shown that glucose acted both transcriptionally and posttranscriptionally, with the latter effect accounting for the majority of the downregulation of PKCbII mRNA.
We have elucidated several molecular mechanisms involved in regulating PKCb gene expression in VSMC. We suggested that acute high glucose could exert important regulatory effects through a putative carbohydrate response element located upstream of the PKCb transcription start site and through glucose-induced posttranscriptional destabilization of PKCbII message via a nuclease activity present in the cytosol. In this case, the rate of mRNA degradation plays an important role in establishing levels of gene expression. Although hormones, growth factors, and ions are known to induce changes in mRNA stability (for review, see ref 39 ), here we determined that PKCbII mRNA levels are regulated primarily by mRNA destabilization in response to glucose, a cellular nutrient. This multilevel regulation of gene expression by glucose suggests that PKCbII may play a pivotal role in vascular smooth muscle cell function.
